Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants von Hehlmann, R, Lauseker, M, Saußele, S, Pfirrmann, M, Krause, S, Kolb, H J, Neubauer, A, Hossfeld, D K, Nerl, C, Gratwohl, A, Baerlocher, G M, Heim, D, Brümmendorf, T H, Fabarius, A, Haferlach, C, Schlegelberger, B, Müller, M C, Jeromin, S, Proetel, U, Kohlbrenner, K, Voskanyan, A, Rinaldetti, S, Seifarth, W, Spieß, B, Balleisen, L, Goebeler, M C, Hänel, M, Ho, A, Dengler, J, Falge, C, Kanz, L, Kremers, S, Burchert, A, Kneba, M, Stegelmann, F, Köhne, C A, Lindemann, H W, Waller, C F, Pfreundschuh, M, Spiekermann, K, Berdel, W E, Müller, L, Edinger, M, Mayer, J, Beelen, D W, Bentz, M, Link, H, Hertenstein, B, Fuchs, R, Wernli, M, Schlegel, F, Schlag, R, de Wit, M, Trümper, L, Hebart, H, Hahn, M, Thomalla, J, Scheid, C, Schafhausen, P, Verbeek, W, Eckart, M J, Gassmann, W, Pezzutto, A, Schenk, M, Brossart, P, Geer, T, Bildat, S, Schäfer, E, Hochhaus, A, Hasford, J

Volltext

Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV von Miranda, M B, Lauseker, M, Kraus, M-P, Proetel, U, Hanfstein, B, Fabarius, A, Baerlocher, G M, Heim, D, Hossfeld, D K, Kolb, H-J, Krause, S W, Nerl, C, Brümmendorf, T H, Verbeek, W, Fauser, A A, Prümmer, O, Neben, K, Hess, U, Mahlberg, R, Plöger, C, Flasshove, M, Rendenbach, B, Hofmann, W-K, Müller, M C, Pfirrmann, M, Hochhaus, A, Hasford, J, Hehlmann, R, Saußele, S

Volltext

Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS) - novel predictors for response and survival in gastric cancer patients von GOEKKURT, E, HOEHN, S, WOLSCHKE, C, WITTMER, C, STUEBER, C, HOSSFELD, D. K, STOEHLMACHER, J

Volltext

Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group von Ryan, G., Martinelli, G., Kuper-Hommel, M., Tsang, R., Pruneri, G., Yuen, K., Roos, D., Lennard, A., Devizzi, L., Crabb, S., Hossfeld, D., Pratt, G., Dell'Olio, M., Choo, S. P., Bociek, R. G., Radford, J., Lade, S., Gianni, A. M., Zucca, E., Cavalli, F., Seymour, J. F.

Volltext

In vitro differentiation of endothelial cells from AC133-positive progenitor cells von GEHLING, U. M, ERGÜN, S, KLUGE, K, SCHÄFER, B, HOSSFELD, D. K, FIEDLER, W, SCHUMACHER, U, WAGENER, C, PANTEL, K, OTTE, M, SCHUCH, G, SCHAFHAUSEN, P, MENDE, T, KILIC, N

Volltext

Time-intensified dexamethasone/cisplatin/cytarabine: an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin’s disease von Josting, A., Rudolph, C., Reiser, M., Mapara, M., Sieber, M., Kirchner, H. H., Dörken, B., Hossfeld, D. K., Diehl, V., Engert, A.

Volltext

Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG) von Josting, A., Rudolph, C., Mapara, M., Glossmann, J.-P., Sienawski, M., Sieber, M., Kirchner, H. H., Dörken, B., Hossfeld, D. K., Kisro, J., Metzner, B., Berdel, W. E., Diehl, V., Engert, A.

Volltext

Randomized Phase III Study of Gemcitabine and Vinorelbine Versus Gemcitabine, Vinorelbine, and Cisplatin in the Treatment of Advanced Non-Small-Cell Lung Cancer: From the German an... von LAACK, E, DICKGREBER, N, KORTSIK, C, GRAEVEN, U, BURK, M, DIERLAMM, T, WELTE, T, BURKHOLDER, I, EDLER, L, HOSSFELD, D. K, MÜLLER, T, KNUTH, A, BENK, J, LORENZ, C, GIESELER, F, DÜRK, H, ENGEL-RIEDEL, W, DALHOFF, K

Volltext

Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment von Gratwohl, A, Pfirrmann, M, Zander, A, Kröger, N, Beelen, D, Novotny, J, Nerl, C, Scheid, C, Spiekermann, K, Mayer, J, Sayer, H G, Falge, C, Bunjes, D, Döhner, H, Ganser, A, Schmidt-Wolf, I, Schwerdtfeger, R, Baurmann, H, Kuse, R, Schmitz, N, Wehmeier, A, Th Fischer, J, Ho, A D, Wilhelm, M, Goebeler, M-E, Lindemann, H W, Bormann, M, Hertenstein, B, Schlimok, G, Baerlocher, G M, Aul, C, Pfreundschuh, M, Fabian, M, Staib, P, Edinger, M, Schatz, M, Fauser, A, Arnold, R, Kindler, T, Wulf, G, Rosselet, A, Hellmann, A, Schäfer, E, Prümmer, O, Schenk, M, Hasford, J, Heimpel, H, Hossfeld, D K, Kolb, H-J, Büsche, G, Haferlach, C, Schnittger, S, Müller, M C, Reiter, A, Berger, U, Saußele, S, Hochhaus, A, Hehlmann, R

Volltext

Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia von FIEDLER, W, GRAEVEN, U, ERGÜN, S, VERAGO, S, KILIC, N, STOCKSLÄDER, M, HOSSFELD, D. K

Volltext

Pretreatment serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in non-small-cell lung cancer von Laack, E., Köhler, A., Kugler, C., Dierlamm, T., Knuffmann, C., Vohwinkel, G., Niestroy, A., Dahlmann, N., Peters, A., Berger, J., Fiedler, W., Hossfeld, D. K.

Volltext

Gender aspects in chronic myeloid leukemia: long-term results from randomized studies von BERGER, U, MAYWALD, O, LÖFFLER, H, PRALLE, H, QUEISSER, W, HEHLMANN, R, PFIRRMANN, M, LAHAYE, T, HOCHHAUS, A, REITER, A, HASFORD, J, HEIMPEL, H, HOSSFELD, D. K, KOLB, H.-J

Volltext

Continuing medical education in Europe: Towards a harmonised system von Costa, A, Van Hemelryck, F, Aparicio, A, Gatzemeier, W, Leer, J.W, Maillet, B, Hossfeld, D.K

Volltext

Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C von MÜLLER, M. C, GATTERMANN, N, KRAUSE, S. W, NERL, C, SAYER, H. G, OTTMANN, O. G, WALLER, C, AULITZKY, W, LE COUTRE, P, FREUND, M, MERX, K, PASCHKA, P, LAHAYE, T, KÖNIG, H, KREIL, S, BERGER, U, GSCHAIDMEIER, H, HEHLMANN, R, HOCHHAUS, A, DEININGER, M. W. N, BERNDT, A, FRUEHAUF, S, NEUHAUER, A, FISCHER, T, HOSSFELD, D. K, SCHNELLER, F

Volltext

Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study von Roy, A, Cunningham, D, Hawkins, R, Sörbye, H, Adenis, A, Barcelo, J-R, Lopez-Vivanco, G, Adler, G, Canon, J-L, Lofts, F, Castanon, C, Fonseca, E, Rixe, O, Aparicio, J, Cassinello, J, Nicolson, M, Mousseau, M, Schalhorn, A, D'Hondt, L, Kerger, J, Hossfeld, D K, Garcia Giron, C, Rodriguez, R, Schoffski, P, Misset, J-L

Volltext

Long-Term Results of First-Line Sequential High-Dose Etoposide, Ifosfamide, and Cisplatin Chemotherapy Plus Autologous Stem Cell Support for Patients With Advanced Metastatic Germ... von SCHMOLL, H.-J, KOLLMANNSBERGER, C, KANZ, L, BERDEL, W. E, ANDREESEN, R, BOKEMEYER, C, METZNER, B, HARTMANN, J. T, SCHLEUCHER, N, SCHÖFFSKI, P, SCHLEICHER, J, RICK, O, BEYER, J, HOSSFELD, D

Volltext

Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphoma von DE WIT, M, BUMANN, D, BEYER, W, HERBST, K, CLAUSEN, M, HOSSFELD, D. K

Volltext

Antiangiogenic treatment with endostatin inhibits progression of AML in vivo von SCHUCH, G, OLIVEIRA-FERRER, L, LOGES, S, LAACK, E, BOKEMEYER, C, HOSSFELD, D. K, FIEDLER, W, ERGUN, S

Volltext

The Apoptosis Inhibitor Gene API2 and a Novel 18q Gene,MLT, Are Recurrently Rearranged in the t(11;18)(q21;q21) Associated With Mucosa-Associated Lymphoid Tissue Lymphomas von Dierlamm, Judith, Baens, Mathijs, Wlodarska, Iwona, Stefanova-Ouzounova, Margarita, Hernandez, Jesus Maria, Hossfeld, Dieter Kurt, De Wolf-Peeters, Christiane, Hagemeijer, Anne, Van den Berghe, Herman, Marynen, Peter

Volltext

Translocations t(11;18)(q21;q21) and t(14;18)(q32;q21) are the main chromosomal abnormalities involving MLT/MALT1 in MALT lymphomas von PENAS, E. M, HINZ, K, DIERLAMM, J, RÖSER, K, COPIE-BERGMAN, C, WLODARSKA, I, MARYNEN, P, HAGEMEIJER, A, GAULARD, P, LÖNING, T, HOSSIELD, D. K

Volltext